Is this email not displaying correctly? View it in your browser.
 
Newswise - News for Journalists
Newswise Special Wire
Tuesday, December 12, 2017

Public edition | newswise.com

Newswise Cancer Research Wire for 12-Dec-2017
 

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.



Medical Marijuana for Children with Cancer? What Providers Think

A study published in Pediatrics examined interdisciplinary provider perspectives on legal medical marijuana use in children with cancer. It found that 92 percent of providers were willing to help children with cancer access medical marijuana. However...

– Ann & Robert H. Lurie Children's Hospital of Chicago

Pediatrics, Dec-2017

Embargo expired on 12-Dec-2017 at 00:05 ET


Faster, More Accurate Cancer Detection Using Nanoparticles, Rutgers-Led Study Finds

Using light-emitting nanoparticles, Rutgers University-New Brunswick scientists have invented a highly effective method to detect tiny tumors and track their spread, potentially leading to earlier cancer detection and more precise treatment. The tech...

– Rutgers University-New Brunswick

Nature Biomedical Engineering; Rutgers Today

Embargo expired on 12-Dec-2017 at 11:00 ET


Pediatric Cancer Providers Give Medical Marijuana a Cautious Thumbs-Up

New research by Yale Cancer Center (YCC) researchers shows a majority of pediatric cancer providers endorse the potential use of medical marijuana for children with advanced cancer, although providers who are legally eligible to certify its use are m...

– Yale Cancer Center

Pediatrics

Embargo expired on 12-Dec-2017 at 00:05 ET


Researchers Develop Test That Can Diagnose Two Cancer Types

A blood test using infrared spectroscopy can be used to diagnose two types of cancer, lymphoma and melanoma, according to a study led by Georgia State University.

– Georgia State University

Scientific Reports


Researchers Identify Epigenetic Orchestrator of Pancreatic Cancer Cells

Genentech researchers have identified an enzyme that shifts pancreatic cancer cells to a more aggressive, drug-resistant state by epigenetically modifying the cells’ chromatin. The study, which will be published December 11 in the Journal of Cell B...

– The Rockefeller University Press

Journal of Cell Biology, February, 2018

Embargo expired on 11-Dec-2017 at 09:00 ET


Cancer Survivors and Financial Stress: The Hidden Secret No One Discusses

So you’ve been diagnosed with cancer. Perhaps you've undergone chemotherapy, radiation, surgery, or a combination of these. Your doctors tell you that you are doing well or perhaps not. Now, the bad news. The bills start piling up: medical bills, ...

– Diseases of the Colon and Rectum Journal

Dis Colon Rectum

Embargo expired on 11-Dec-2017 at 10:00 ET


Safety Net Hospitals: Are the Uninsured Getting Good Quality Cancer Care?

You have no insurance, and you are diagnosed with a colon and rectal cancer. You may be one of the thousands of patients in the United States who find themselves being taken care of at a “safety net hospital.” These are hospitals that are require...

– Diseases of the Colon and Rectum Journal

Embargo expired on 11-Dec-2017 at 10:00 ET


Study Identifies Agent That Can Reverse Resistance to Targeted Drug in Some Leukemia Cell Types

• Azacitidine reverses resistance to SL-401 in AML and BPDCN cell lines, researchers find • Results prompt clinical trial of SL-401 and azacitidine in AML and MDS patients

– Dana-Farber Cancer Institute

ASH #797

Embargo expired on 11-Dec-2017 at 17:30 ET


Soy, Cruciferous Vegetables Associated with Fewer Common Side Effects of Breast Cancer Treatment

Consuming soy foods (such as soy milk, tofu and edamame) and cruciferous vegetables (such as cabbages, kale, collard greens, bok choy, Brussels sprouts, and broccoli) may be associated with a reduction in common side effects of breast cancer treatmen...

– Georgetown Lombardi Comprehensive Cancer Center

Breast Cancer Research and Treatment

Embargo expired on 11-Dec-2017 at 00:05 ET


Blueprints for Anti-Cancer Drugs Discovered in Bacterial Genomes

New research suggests these hidden genes hold the blueprints for designing new, even more effective cancer-targeting compounds.

– Scripps Research Institute

Proceedings of the National Academy of Sciences, Dec. 2017; 2011ZX09401-001; 2012AA02A705; CA106150

Embargo expired on 11-Dec-2017 at 15:00 ET


AML Study Reports High Response Rates with Combination Targeted Therapy

Initial findings from a multi-national open-label phase Ib study of inhibitory drug therapy for relapsed or refractory acute myeloid leukemia (AML) have demonstrated a complete response in up to 50 percent patients say researchers at The University o...

– University of Texas M. D. Anderson Cancer Center

Annual Meeting & Exposition

Embargo expired on 11-Dec-2017 at 12:00 ET


Increasing Physical Activity Improves Survival in Lymphoma Patients, Mayo Researchers Say

An observational study by researchers at Mayo Clinic has found that increasing physical activity not only decreased the risk of death from all causes but also decreased the risk of death specifically from lymphoma.

– Mayo Clinic

Embargo expired on 11-Dec-2017 at 19:45 ET


Study Identifies Barriers to Transplant Therapy to Treat Multiple Myeloma Among Racial Minority Groups

A study by researchers at Mayo Clinic’s campus in Jacksonville, Florida has found that barriers to patients receiving stem cell therapy as part of their treatment for multiple myeloma include income, education, insurance status and access to care a...

– Mayo Clinic

Embargo expired on 11-Dec-2017 at 18:00 ET


‘Black Box’ Recorder Puts Surgeons’ Robotic Surgery Skills Under the Microscope

A new study from Keck Medicine of USC finds that data from a novel recorder can be used to objectively measure surgeons’ proficiency in robotic-assisted prostate cancer surgery.

– Keck Medicine of USC

The Journal of Urology


Roswell Park Hematology Experts Sharing New Research in ASH 2017 Podium Presentations

Dr. Eunice Wang was invited to discuss results of a phase II clinical trial of crenolanib for adults with AML at the ASH 2017 annual meeting, and Dr. Kara Kelly, senior author of an oral abstract on outcomes disparities among children and adolescents...

– Roswell Park Cancer Institute

ASH annual meeting 2017


Insights on How SHARPIN Promotes Cancer Progression

SBP and Technion Institute researchers have SHARPIN-ed their knowledge of how a malicious form of a protein drives the formation of melanoma through modulation of the PRMT5 pathway. The new research was published in The Journal of Clinical Investigat...

– Sanford Burnham Prebys Medical Discovery Institute

Journal of Clinical Investigation; R35CA197465; R21CA198468


Report: New System for More Accurate Cancer Staging to Aid Precision Medicine

Adding a blood test called liquid biopsy to a standard tissue biopsy could significantly improve the accuracy of diagnosis and treatment for patients with cancer, according to researchers at Wake Forest Baptist Medical Center.

– Wake Forest Baptist Medical Center

Annals of Oncology, Dec-2017


Scientists Discover Possible Master Switch for Programming Cancer Immunotherapy

How do killer T cells “learn” to leave their home base and amass within specific tissues like the skin, gut, and lung, or solid tumors?

– Scripps Research Institute

Nature, Dec. 2017; U19AI109976; R01AI095634; RB5-07012


Scientists Identify Promising New Approach forImmune System Defense Against Cancer

Researchers have identified a promising new strategy to fight infections and cancer. They uncovered a novel function for a protein known as “Runx3” that is key to the development of killer T cells—immune cells important for fighting infections ...

– University of California San Diego

Nature, Dec-2017


Drug Suppresses Spread of Breast Cancer Caused by Stem-Like Cells

Rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway that powers them offers a strategy to target these cells using existing drugs before metastatic disease occurs, report University of Ca...

– University of California San Diego Health

Journal of Clinical Investigation


Kyra’s Legacy

Pets have become an integral part of human medical research. However, a recent collaboration between Penn Med and Penn Vet has turned the tables on the arrangement.

– Perelman School of Medicine at the University of Pennsylvania

Dogs in Review; PLOS One


Phase 2 CAR-T Study Reports Significant Remission Rates at 15-Month Follow Up

A study involving the recently approved CD19-targeting chimeric antigen receptor (CAR) T cell therapy shows that 42 percent of patients with aggressive large B-cell lymphoma remained in remission at 15 months following treatment with axi-cel (markete...

– University of Texas M. D. Anderson Cancer Center

The New England Journal of Medicine; American Society of Hematology

Embargo expired on 10-Dec-2017 at 10:30 ET


Landmark CAR-T Cancer Study Published in the New England Journal of Medicine

Loyola University Medical Center is the only Chicago center that participated in the pivotal clinical trial of a groundbreaking cancer treatment that genetically engineers a patient's immune system to attack cancer cells.

– Loyola University Health System

New England Journal of Medicine

Embargo expired on 10-Dec-2017 at 00:00 ET


Sequencing Offers Clues to Progression Toward Multiple Myeloma

Researchers at Dana-Farber Cancer Institute have carried out the largest genomic analysis of patients with smoldering multiple myeloma (SMM), a precursor to full-blown blood cancer that doesn’t show outward symptoms.

– Dana-Farber Cancer Institute

ASH #392

Embargo expired on 10-Dec-2017 at 09:45 ET


Tracking How Multiple Myeloma Evolves by Sequencing DNA in the Blood

Although people with multiple myeloma usually respond well to treatment, the blood cancer generally keeps coming back. Following genetic changes in how the disease evolves over time will help to understand the disease and, eventually, deliver more ef...

– Dana-Farber Cancer Institute

ASH #329

Embargo expired on 10-Dec-2017 at 08:30 ET


Rapid Responses, Few Adverse Effects Seen with Targeted Agent in Phase 1 Trial in Rare Blood Disorder

• Clinical Activity in a Phase 1 Study of BLU-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis • Study shows one of multiple ways in which novel targeted cancer therapies are now being deployed to improv...

– Dana-Farber Cancer Institute

ASH #2

Embargo expired on 10-Dec-2017 at 08:00 ET


Study Shows Combining Chemotherapy with Targeted Drug Boosts Response in Chronic Lymphocytic Leukemia

Among younger patients newly diagnosed with chronic lymphocytic leukemia (CLL), treatment with a combination of chemotherapy and a molecularly targeted drug significantly improves response over what is typically seen with chemotherapy alone, accordin...

– Dana-Farber Cancer Institute

ASH #496

Embargo expired on 10-Dec-2017 at 17:15 ET


Low-Dose Treatment with Interleukin-2 Across Multiple Studies Shows Benefits in Chronic Graft-Versus-Host Disease

Daily low doses of the immune signaling protein interleukin-2 (IL-2) can safely benefit patients who develop chronic graft-versus-host disease following stem cell transplants, including particular benefit in pediatric patients in one small study, rep...

– Dana-Farber Cancer Institute

ASH #s 74; ASH #511; ASH #515; ASH #3248

Embargo expired on 10-Dec-2017 at 06:00 ET


Global CAR T Therapy Trial Shows High Rates of Durable Remission for Non-Hodgkin’s Lymphoma

In a pair of clinical trials stretching from Philadelphia to Tokyo, the chimeric antigen receptor (CAR) T cell therapy Kymriah™ (formerly known as CTL019) demonstrated long-lasting remissions in non-Hodgkin’s lymphoma (NHL) patients. Results from...

– Perelman School of Medicine at the University of Pennsylvania

ASH Annual Meeting; 1R01CA165206

Embargo expired on 10-Dec-2017 at 10:30 ET


CAR T, Immunotherapy Bring New Hope for Multiple Myeloma Patients

Two investigational immunotherapy approaches, including chimeric antigen receptor (CAR) T cell therapy, have shown encouraging results in the treatment of multiple myeloma patients who had relapsed and were resistant to other therapies. Researchers f...

– Perelman School of Medicine at the University of Pennsylvania

59th American Society of Hematology Annual Meeting

Embargo expired on 10-Dec-2017 at 16:30 ET


Immunotherapy Drug for Rheumatoid Arthritis Nearly Eliminates Severe Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplant

Results from a phase 2 clinical trial, presented by Seattle Children’s Research Institute at the 59th American Society of Hematology (ASH) Annual Meeting, show that the drug Abatacept (Orencia) nearly eliminated life-threatening severe acute graft-...

– Seattle Children's Hospital

American Society of Hematology Annual Meeting, Dec-2017

Embargo expired on 09-Dec-2017 at 14:00 ET


Study Explores Use of Checkpoint Inhibitors After Relapse From Donor Stem Cell Transplant for Hematologic Cancers

Immunotherapy agents known as checkpoint inhibitors have shown considerable promise in patients with hematologic cancers who relapse after a transplant with donor stem cells. Preliminary results from the first clinical trial in these patients of one ...

– Dana-Farber Cancer Institute

ASH #275

Embargo expired on 09-Dec-2017 at 17:00 ET


Using Software, Researchers Predict Tumor Markers That Could Be Immune Targets

Researchers report at the 59th Annual American Society for Hematology Annual Meeting in Atlanta on Saturday, Dec. 9, that they were able to validate their approach for predicting markers – called minor histocompatibility antigens – in a group of ...

– University of North Carolina Health Care System

59th American Society of Hematology Annual Meeting

Embargo expired on 09-Dec-2017 at 14:00 ET


Immunotherapy Strategy Could Be Beneficial for Relapsed Acute Myeloid Leukemia, Preliminary Data Show

Researchers present their preliminary results from the ongoing phase II trial of chemotherapy and pembrolizumab in relapsed or refractory acute myeloid leukemia at the 59th American Society of Hematology Annual Meeting in Atlanta on Saturday, Dec. 9....

– University of North Carolina Health Care System

59th American Society of Hematology Annual Meeting

Embargo expired on 09-Dec-2017 at 17:30 ET


For Women with Genetic Risk, Bi-Annual MRI Beats Mammograms

Intensive surveillance including a dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) exam every six months was far more effective in detecting breast cancer in younger women with a high-risk genetic profile than an annual mammogram. DCE-...

– University of Chicago Medical Center

San Antonio Breast Cancer Symposium, 2017

Embargo expired on 08-Dec-2017 at 18:00 ET


Including Diagnosis Related Costs, 3-D Mammography Costs Less than Digital Mammography

Although digital breast tomosynthesis (DBT), or 3-D mammography, costs more than a digital mammography (DM) screening, it actually may help rein in cancer screening costs, according to preliminary findings (PD7-05) presented by researchers from the P...

– Perelman School of Medicine at the University of Pennsylvania

2017 San Antonio Breast Cancer Symposium

Embargo expired on 08-Dec-2017 at 08:00 ET


New Mediola and OlympiAD Trial Results Offer Another Boon for PARP Inhibitors in Treatment of Advanced BRCA-Related Breast Cancer

Patients with certain advanced hereditary breast cancers may have new treatments options on the horizon, according to two studies presented this week at the annual San Antonio Breast Cancer Symposium. Susan Domchek, MD, executive director of the Bass...

– Perelman School of Medicine at the University of Pennsylvania

San Antonio Breast Cancer Symposium

Embargo expired on 08-Dec-2017 at 18:00 ET


PARP Inhibitor Improves Progression-Free Survival in Patients with Advanced Breast Cancers and BRCA Mutations

In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for ...

– University of Texas M. D. Anderson Cancer Center

San Antonio Breast Cancer Symposium


The Structure of Cool

A team of researchers from The Scripps Research Institute (TSRI) and Duke University has made the first determination of the atomic structure of Transient Receptor Potential Melastatin 8 (TRPM8), a molecular sensor in nerve ends that detects cold tem...

– Scripps Research Institute

Science, Nov. 2017; R35NS097241; DP2EB020402

Embargo expired on 07-Dec-2017 at 14:00 ET


Research Suggests New Pathways for Hyperaldosteronism

Scientists have identified a mechanism that explains the development of hyperaldosteronism, a condition in which the adrenal glands produce too much aldosterone, The findings, published in JCI Insight, offer a path for drug discovery to treat the c...

– Sanford Burnham Prebys Medical Discovery Institute

JCI Insight; R35 CA197465-01


Study Shows Acupuncture Decreased Joint Pain in Breast Cancer Patients Treated with Aromatase Inhibitors

Acupuncture decreased joint symptoms in women with early-stage breast cancer treated with aromatase inhibitors, according to a randomized, multicenter clinical trial led by researchers at NewYork-Presbyterian and Columbia University Irving Medical Ce...

– New York-Presbyterian Hospital

San Antonio Breast Cancer Symposium


Biological Factors Don’t Completely Explain Racial Disparities for ‘Good Prognosis’ Breast Cancer

The biological features of patients’ tumors partially explained a racial disparity for women with hormone receptor-positive, HER2-negative breast cancer, but UNC Lineberger researchers led by Katherine Reeder-Hayes, MD, MBA, MSc, said it didn’t e...

– University of North Carolina Health Care System

2017 San Antonio Breast Cancer Symposium


Prostate Cancer: UVA Aims to Help Men Make Complex Care Decisions

Researchers are developing a tool to help patients with prostate cancer better understand the potential risks and rewards of their treatment options. The tool eventually will help patients with other cancers as well.

– University of Virginia Health System


Ribociclib Extends Progression-Free Survival in Pre-Menopausal Patients with Metastatic Hormone Receptor-Positive Breast Cancer

The addition of ribociclib, an inhibitor of the cell cycle, to standard hormone therapy significantly improved progression-free survival (PFS) in pre-menopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to result...

– University of Texas M. D. Anderson Cancer Center


La Mamografía Digital Con Realce Por Contraste Es Comparable a La Resonancia MagnéTica De Las Mamas DespuéS Del Tratamiento O De La Quimioterapia

La mamografía digital con realce por contraste es comparable a la resonancia magnética de las mamas para evaluar el cáncer mamario residual después de la terapia endocrina adyuvante o de la quimioterapia, según los resultados de un estudio prese...

– Mayo Clinic


Dr. Mohamad Cherry of Atlantic Hematology Oncology Leads Meeting Session and Helps Present Multiple Studies at Top International Blood Cancer Meeting

Mohamad Cherry, MD, leads a major session on new discoveries about the most common type of acute adult leukemia and helps present results of four major blood cancer studies at the American Society of Hematology (ASH) 59th Annual Meeting, December 9-1...

– Atlantic Health System


#FiercePierce: 2-Year-Old Patient Beats Back Leukemia and Inspires Thousands of Potential Stem Cell Donors

2-year-old Children's Hospital Los Angeles patient Pierce Kelly beats leukemia thanks to a stem cell donor in France and inspires thousands of potential donors.

– Childrens Hospital Los Angeles


Novel Regulation of Gene Expression in Brain Tumors Identified

Study results revealed previously unknown interplay between two key enzymes and a novel understanding of how brain cancer tumors form and spread, according to researchers at The University of Texas MD Anderson Cancer Center.

– University of Texas M. D. Anderson Cancer Center

Nature

Embargo expired on 06-Dec-2017 at 13:00 ET


Contrast-Enhanced Digital Mammography Comparable to Breast MRI in Evaluating Residual Breast Cancer After Systemic Neoadjuvant Therapy

Contrast-enhanced digital mammography is comparable to breast MRI in evaluating residual breast cancer after neoadjuvant endocrine therapy or chemotherapy, according to the results of a study presented by Mayo Clinic researchers today at the 2017 San...

– Mayo Clinic

2017 San Antonio Breast Cancer Symposium

Embargo expired on 06-Dec-2017 at 18:00 ET


Study Finds Colorectal Cancer Cells and Bacteria to Be Fellow Travelers During Metastasis

Like nomads who carry tokens of home on their travels, colorectal cancer cells that spread to other parts of the body appear to bring several of the species of bacteria that were their companions in the colon, Dana-Farber Cancer Institute scientists ...

– Dana-Farber Cancer Institute

Science


Breakthroughs in Understanding the Genetic Basis of Aggressive Prostate Cancer

New research shows how losing a ubiquitous gene opens genetic floodgates that make prostate cancer deadly, a finding that could apply to many cancers.

– Thomas Jefferson University

The Journal of Clinical Investigation


A Blueprint to Advance Colorectal Cancer Immunotherapies

Fight Colorectal Cancer (Fight CRC) and the Cancer Research Institute (CRI) are proud to announce “A Blueprint to Advance Colorectal Cancer Immunotherapies”

– Cancer Research Institute

Cancer Immunology Research


Unique 3D Printer Creates Realistic Model of Patient Prostate, Aims to Vastly Improve Surgical Outcomes

NIBIB-funded scientists have developed a new technique for 3D-printing patient-specific organ models – here the prostate gland -- using polymers that accurately model the prostate’s dimensions and physical properties, while also providing quantit...

– National Institute of Biomedical Imaging and Bioengineering

Advanced Materials Tech, Dec-2017; EB020537


Study First to Sequence DNA From a Single Mitochondria

DNA sequences between mitochondria within a single cell are vastly different, found researchers. This knowledge will help to better illuminate the underlying mechanisms of many disorders that start with accumulated mutations in individual mitochondri...

– Perelman School of Medicine at the University of Pennsylvania

Cell Reports


NUS Researchers Uncover Novel Pathway to Suppress Virus-Induced Cancers

Researchers at the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have identified a novel molecular pathway by which a tumour suppressor, TIP60, inhibits the growth of cancer cells.

– National University of Singapore

PLOS Pathogens


Study Uses Genetic Testing to Personalize Treatment for Deadly Blood Cancer

A clinical trial using genetic testing to match acute myeloid leukemia (AML) patients with new therapies is now open at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). The center is one of seven cancer ...

– University of Maryland Medical Center/School of Medicine


Mount Sinai Surgeons Remove Cancerous Lymph Nodes in the Neck Through Hidden Scar Procedure

A team of surgeons at Mount Sinai Beth Israel have performed the first robot-assisted radical neck dissection in the United States using the bilateral axillo-breast approach (BABA), a surgery that involves removing all of the lymph nodes on one side ...

– Mount Sinai Health System

VideoEndocrinology, Dec-2017


In Multiple Myeloma, High Levels of Enzyme ADAR1 are Associated with Reduced Survival

Using a database of multiple myeloma patient samples and information, researchers at University of California San Diego School of Medicine found that high ADAR1 levels correlate with reduced survival rates. They also determined that blocking the enzy...

– University of California San Diego Health

Nature Communications


Announcements


Dana-Farber/Brigham and Women’s physician wins prestigious 2017 William Dameshek Prize from the American Society of Hematology

• Benjamin Ebert, MD, PhD, current chair of Medical Oncology, was presented with recognition at annual American Society of Hematology meeting • Ebert is notable for his leadership in describing the genomic landscape of adult myelodysplastic s...

– Dana-Farber Cancer Institute

ASH

Embargo expired on 12-Dec-2017 at 09:30 ET


Riverview Medical Center Welcomes Robert Paul Bonitz, M.D., Urological Surgeon

Hackensack Meridian Health Riverview Medical Center in Red Bank, NJ is pleased to welcome Robert Paul Bonitz, M.D., to the medical staff. Dr. Bonitz specializes in urology and joins the strong team of surgeons at Riverview Medical Center.

– Hackensack Meridian Health


Complimentary Press Registration Available for 2018 Winter Rheumatology Symposium

The American College of Rheumatology (ACR) welcomes members of the press to write about rheumatology research presented the Winter Rheumatology Symposium in Snowmass Village, CO on January 20-26, 2018.

– American College of Rheumatology (ACR)

Winter Rheumatology Symposium


The Cancer Research Institute Announces Publication of Comprehensive Immuno-Oncology Landscape Analysis in Annals of Oncology

Comprehensive immuno-oncology landscape analysis conducted by nonprofit Cancer Research Institute quantifies global development of immunotherapy and identifies opportunities to advance the field to improve patient care

– Cancer Research Institute

Annals of Oncology, Dec-2017; European Society of Clinical Oncology IO Congress 2017

Embargo expired on 07-Dec-2017 at 06:15 ET


Nobel Prize: Circadian Rhythm Field Poised for Medical Advances

The field of circadian rhythms is being recognized with a Nobel Prize this year for the discovery of a fruit fly gene controlling the biological clock. But a series of more recent advancements – notably the first circadian gene in mammals discovere...

– UT Southwestern Medical Center


National Experts Map Out Adolescent and Young Adult (AYA) Cancer Research Agenda

Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine, are focusing their efforts on adolescent and young adult (AYA) cancer research. More than 50 leaders from top cancer research institutions will...

– Case Western Reserve University

AYA National Research Strategy Meeting


Viviane Tabar, MD, Named Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center

Viviane Tabar, MD, has been named the new Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center (MSK). Dr. Tabar has been a vital faculty member at MSK for more than 15 years and is currently the Theresa C. Feng Chair for ...

– Memorial Sloan Kettering Cancer Center

Embargo expired on 06-Dec-2017 at 12:00 ET


Expert Pitch


Loyola Medicine Oncologist Patrick Stiff, MD, Co-Author of Landmark @NEJM CAR-T Study, Offers Measured Evaluation of Therapy.

– Loyola University Health System

Embargo expired on 10-Dec-2017 at 10:30 ET


NEJM to Pub 2 CAR T-Cell Therapy Studies. David Maloney, Head of Fred Hutch Clinical Immunotherapy Research, Can Discuss

– Fred Hutchinson Cancer Research Center


Drug Offers New Hope to Fight Relapse in People with Kidney Cancer

– University of California, Los Angeles (UCLA), Health Sciences

Tips

CUSTOMIZE YOUR FAVORITES WITH "MY READING LIST"

MY CHANNELS  |  SAVED ARTICLES  |  MY SOURCES  |  MY EXPERTS

MORE CHANNELS:
JOURNAL NEWS   |  TRENDS AND TOP STORIES   |  LOCAL NEWS  |  MEDICAL and SCIENTIFIC MEETINGS

Support
 Subscribe/Unsubscribe
 Edit My Preferences
 Comments/Suggestions
 Contact Us
 
Services
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 University of Texas M. D. Anderson Cancer Center

 University of California San Diego Health

 The Rockefeller University Press

 University of Virginia Health System

 Diseases of the Colon and Rectum Journal

 Seattle Children's Hospital

 Washington University in St. Louis

 Georgia State University

 UT Southwestern Medical Center

 University of California, Los Angeles (UCLA), Health Sciences


Subscribe / Unsubscribe
Edit my preferences

© 2017 Newswise, Inc. All Rights Reserved.

215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417

 Contact Us